Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) accounts for ∼50% of all clinical presentations of heart failure, (HF) and its prevalence is expected to increase. However, there are no evidence-based therapies for HFpEF; thus, HFpEF represents a major unmet need. Although hypertension is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Komei, Valero-Muñoz, María, Wilson, Richard M., Essick, Eric E., Fowler, Conor T., Nakamura, Kazuto, van den Hoff, Maurice, Ouchi, Noriyuki, Sam, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
PRE-CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944656/
https://www.ncbi.nlm.nih.gov/pubmed/27430031
http://dx.doi.org/10.1016/j.jacbts.2016.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944656/
https://www.ncbi.nlm.nih.gov/pubmed/27430031
http://dx.doi.org/10.1016/j.jacbts.2016.04.002

Ejemplares similares